Profound Medical Corp
TSX:PRN
Profound Medical Corp
TSX:PRN
Price:
10.84 CAD
-3.73%
Market Closed
Updated:
Apr 29, 2024
Profound Medical Corp
Cash from Financing Activities
|
Profound Medical Corp
Cash from Financing Activities Peer Comparison
Comparables:
NVCN
OPS
NSCI
TLT
MIR
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Cash from Financing Activities
$1.5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
Neovasc Inc
TSX:NVCN
|
Cash from Financing Activities
-$762.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Opsens Inc
TSX:OPS
|
Cash from Financing Activities
CA$10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Cash from Financing Activities
CA$13.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
128%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Cash from Financing Activities
CA$2.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
MedMira Inc
XTSX:MIR
|
Cash from Financing Activities
CA$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
29%
|
CAGR 10-Years
-7%
|
See Also
What is Profound Medical Corp's Cash from Financing Activities?
Cash from Financing Activities
1.5m
USD
1.5m
USD
Based on the financial report for Dec 31, 2023, Profound Medical Corp's Cash from Financing Activities amounts to 1.5m USD.
What is Profound Medical Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-45%
-45%
Over the last year, the Cash from Financing Activities growth was -79%. The average annual Cash from Financing Activities growth rates for Profound Medical Corp have been -74% over the past three years , -45% over the past five years .
You don't have any saved screeners yet
